Antonino Scibilia

Antonino Scibilia

Auto-generated profile, based on publicly available information

Antonino Scibilia

Department of Neurosurgery, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Neurosurgical Focus
Verified
Journal Article
Closed access
ASAntonino Scibilia
Antonino Scibilia
CTCarmen Terranova
Carmen Terranova
VRVincenzo Rizzo
Vincenzo Rizzo
Giovanni RaffaGiovanni Raffa
Giovanni Raffa
AMAdolfo Morelli
Adolfo Morelli
AGAntonino Germanò
Antonino Germanò
Spinal tumor (ST) surgery carries the risk of new neurological deficits in the postoperative period. Intraoperative neurophysiological monitoring and mapping (IONM) represents an effective method of identifying and monitoring in real time the functional integrity of both the spinal cord (SC) and the nerve roots (NRs). Despite consensus favoring the use of IONM in ST surgery, in this era of evidence-based medicine, there is still a need to demonstrate the effective role of IONM in ST surgery in achieving an oncological cure, optimizing patient safety, and considering medicolegal aspects. Thus, neurosurgeons are asked to establish which techniques are considered indispensable. In the present study, the authors focused on the rationale for and the accuracy (sensitivity, specificity, and positive and negative predictive values) of IONM in ST surgery in light of more recent evidence in the literature, with specific emphasis on the role of IONM in reducing the incidence of postoperative neurological deficits. This review confirms the role of IONM as a useful tool in the workup for ST surgery. Individual monitoring and mapping techniques are clearly not sufficient to account for the complex function of the SC and NRs. Conversely, multimodal IONM is highly sensitive and specific for anticipating neurological injury during ST surgery and represents an important tool for preserving neuronal structures and achieving an optimal postoperative functional outcome.


1 January 2017
Verified
Book Chapter
Closed access
PDF file
ASAntonino Scibilia
Antonino Scibilia
Giovanni RaffaGiovanni Raffa
Giovanni Raffa
VRVincenzo Rizzo
Vincenzo Rizzo
AQAngelo Quartarone
Angelo Quartarone
MVMassimiliano Visocchi
Massimiliano Visocchi
FTFrancesco Tomasello
Francesco Tomasello

1 October 2020 in World Neurosurgery
Verified
Journal Article
Closed access
ARAntonio Romano
Antonio Romano
Mario GanauMario Ganau
Mario Ganau
IZIsmail Zaed
Ismail Zaed
ASAntonino Scibilia
Antonino Scibilia
GOGabriele Oretti
Gabriele Oretti
Salvatore ChibbaroSalvatore Chibbaro
Salvatore Chibbaro

1 December 2011 in Journal of Neurotrauma
Verified
Journal Article
Closed access
LMLucia Merlo
Lucia Merlo
Francesco CiminoFrancesco Cimino
Francesco Cimino
ASAntonino Scibilia
Antonino Scibilia
ERElisabetta Ricciardi
Elisabetta Ricciardi
JCJoselita Chirafisi
Joselita Chirafisi
AGAntonino Germanò
Antonino Germanò
In the present study we assessed the neuroprotective effects of simvastatin in a rodent model of experimental subarachnoid hemorrhage (SAH). Based on recent data showing the role of statins not only in lowering the level of cholesterol but also in preventing cardiac and cerebrovascular damage in risk population, and in decreasing vasospasm and delayed ischemia after aneurysmal SAH, we investigated the neuroprotective effects of intraperitoneal administration of simvastatin (40 mg/kg/day for 5 consecutive days) in Sprague-Dawley rats 30 min after SAH, as compared to vehicle-treated SAH animals. We employed a battery of well-characterized tests to assess memory, learning, motivational, balance, and behavioral performances. On days 1–4 post-SAH, simvastatin-treated rats have significantly improved beam balance scores (days 1–2, p <0.001; days 3–4, p <0.01), beam balance times (days 1–4, p <0.01), and latency to traverse the beam (days 1–3, p <0.01; day 2, p <0.005; day 4, p <0.0001) in comparison with control groups that, conversely, were not protected against SAH-related body weight changes. These results demonstrate that the administration of simvastatin may represent a beneficial therapeutic approach able to reduce post-SAH cognitive dysfunction.

7 March 2024 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
PPPietro Panni
Pietro Panni
FSFranco Simionato
Franco Simionato
RCRoberta Cao
Roberta Cao
APAlessandro Pedicelli
Alessandro Pedicelli
Enrico MarcheseEnrico Marchese
Enrico Marchese
OIon behalf of the POGASH Investigators
on behalf of the POGASH Investigators
BACKGROUND AND PURPOSE: Early brain injury is a major determinant of clinical outcome in poor-grade (World Federation of Neurosurgical Societies [WFNS] IV–V) aneurysmal SAH and is radiologically defined by global cerebral edema. Little is known, though, about the effect of global intracranial hemorrhage volume on early brain injury development and clinical outcome. MATERIALS AND METHODS: Data from the multicentric prospective Poor-Grade Aneurysmal Subarachnoid Hemorrhage (POGASH) Registry of consecutive patients with poor-grade aneurysmal SAH admitted from January 1, 2015, to August 31, 2022, was retrospectively evaluated. Poor grade was defined according to the worst-pretreatment WFNS grade. Global intracranial hemorrhage volume as well as the volumes of intracerebral hemorrhage, intraventricular hemorrhage, and SAH were calculated by means of analytic software in a semiautomated setting. Outcomes included severe global cerebral edema (defined by Subarachnoid Hemorrhage Early Brain Edema Score grades 3–4), in-hospital mortality (mRS 6), and functional independence (mRS 0–2) at follow-up. RESULTS: Among 400 patients (median global intracranial hemorrhage volume of 91 mL; interquartile range, 59–128), severe global cerebral edema was detected in 218/400 (54.5%) patients. One hundred twenty-three (30.8%) patients died during the acute phase of hospitalization. One hundred fifty-five (38.8%) patients achieved mRS 0–2 at a median of 13 (interquartile range, 3–26) months of follow-up. Multivariable analyses showed global intracranial hemorrhage volume as independently associated with severe global cerebral edema (adjusted OR, 1.009; 95% CI, 1.004–1.014; P < .001), mortality (adjusted OR, 1.006; 95% CI, 1.001–1.01; P = .018) and worse clinical outcome (adjusted OR, 0.992; 95% CI, 0.98–0.996; P < .010). The effect of global intracranial hemorrhage volume on clinical-radiologic outcomes changed significantly according to different age groups (younger than 50, 50–70, older than 70 year of age). Volumes of intracerebral hemorrhage, intraventricular hemorrhage, and SAH affected the 3 predefined outcomes differently. Intracerebral hemorrhage volume independently predicted global cerebral edema and long-term outcome, intraventricular hemorrhage volume predicted mortality and long-term outcome, and SAH volume predicted long-term clinical outcome. CONCLUSIONS: Global intracranial hemorrhage volume plays a pivotal role in global cerebral edema development and emerged as an independent predictor of both mortality and long-term clinical outcome. Aging emerged as a reducing predictor in the relationship between global intracranial hemorrhage volume and global cerebral edema.